• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthMarijuana

Seattle Moves to Wipe Out 2 Decades Of Marijuana Possession Convictions

By
David Z. Morris
David Z. Morris
By
David Z. Morris
David Z. Morris
April 28, 2018, 1:17 PM ET

The City of Seattle has filed a motion in municipal court to vacate – that is, retroactively void – all misdemeanor marijuana convictions in the city. According to a statement from Mayor Jenny Durkan, the request would effect 542 people. The city has also requested the dismissal of outstanding misdemeanor possession charges. In 2012, Washington became the first U.S. state to legalize marijuana for recreational use.

As marijuana prohibition ends in states across the U.S., the impact of past laws is being considered in a new light. Durkan echoed a growing consensus in describing Seattle’s move as an “important step to right the wrongs [of] the failed war on drugs.” She particularly focused on drug laws impacts on people of color, who have for decades been convicted under aggressive drug laws at disproportionately high rates relative to whites.

Get Data Sheet, Fortune’s technology newsletter.

That injustice has become even more glaring as legal marijuana spawns an above-board industry that could grow to $50 billion within a decade, but which does not appear poised to benefit the very minorities who were so abused by earlier drug laws. That bleak irony was hammered home earlier this month when John Boehner, a former leader in the political party that formally initiated the War on Drugs, joined the advisory board of a marijuana firm.

Seattle’s attempt to rebalance those scales, at least in a minor way, follows a February move by Philadelphia to stop criminally prosecuting low-level marijuana offenses.

There is growing evidence that marijuana has a range of medical applications and health benefits. Perhaps most strikingly, recent evidence has shown that states with legal marijuana have lower rates of opiate use. That could help curtail a true drug crisis with devastating economic and social impacts – and which was sparked, in large part, by the actions of huge pharmaceutical companies.

About the Author
By David Z. Morris
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.